七月四项值得关注的医疗科技融资公告
4 Notable Health Tech Funding Announcements in July
编者按：本汇总旨在突出本月部分最值得关注的融资轮次，并非全面盘点。
医疗科技公司在七月发布了多项重大融资公告。以下是一些最大规模融资轮次的列表。
Function 获得 4.5 亿美元融资由以下机构呈现赞助文章2026 年全球劳动力十大现代 AI 驱动 EAP 提供商发现 2026 年顶级 AI 驱动 EAP 提供商。比较 Kyan Health 和 Spring Health 等平台在分诊速度、全球覆盖范围及临床质量方面的表现，以改善员工福祉。
作者：Tiffany Cabasso，Kyan Health 运营总监 | 心理学家，FSP总部位于德克萨斯州奥斯汀的Function Health是一个平台，让消费者能够获得超过 160 种不同的实验室检测，包括激素、心脏健康、免疫和代谢方面。该平台年度订阅费用为 365 美元。
其4.5 亿美元的成长融资来自 General Catalyst 的客户价值基金。根据公告，这笔资金将帮助 Function “更快地将平台带给数百万更多人”。
Chai Discovery 完成 4 亿美元 C 轮融资
总部位于旧金山的 Chai Discovery 开发了一套用于分子的计算机辅助设计套件。它训练模型学习生化结构和相互作用的基础，以帮助科学家设计新药。
由以下机构呈现赞助文章弥合职场心理健康中质量与可负担性之间的差距在一次采访中，Kyan Health 联合创始人兼首席商务官 Konstantin Struck 讨论了 Kyan 如何以可负担的价格为中端市场和企业雇主提供高品质的员工心理保健服务。
作者：Stephanie Baum其C 轮融资由 Index Ventures 领投，Kleiner Perkins、Sequoia Capital 和 Dimension 参与投资。参与方还包括 Bain Capital Ventures、Battery Ventures、Baillie Gifford、BDT & MSD、Sapphire Ventures、Avra Capital、Thrive Capital、OpenAI、Oak HC/FT、Menlo Ventures、General Catalyst、Glade Brook、Avenir、Lachy Groom 和 Yosemite。Chai Discovery 目前估值为 38 亿美元。
Candid Health 获得 1.2 亿美元 D 轮融资总部位于旧金山的Candid Health服务于医疗团体、管理服务组织和数字健康公司。其 AI 驱动系统自动化医疗计费和健康保险理赔，帮助提供商更准确、更快速地获得付款。它支持超过 200 家医疗机构，包括 Talkiatry、Tia、Luna、Cortica 和 Nourish。Candid Health 表示，这笔资金将支持持续投资于自动化、加速代理式 RCM 解决方案的开发并扩大团队。
D 轮融资由 Sixth Street Growth 领投，Oak HC/FT、8VC 和 Y Combinator 参与投资。此前，Candid Health 于 2025 年 2 月完成了由 Oak HC/FT 领投的 5250 万美元C 轮融资。Candid Health 累计融资约 2.19 亿美元。
Pearl Health 获得 1.1 亿美元融资总部位于纽约的Pearl Health通过提供 AI 驱动的预测性洞察、财务风险建模和更高效的工作流程，支持临床医生和护理组织参与基于价值的护理。其平台帮助识别高风险患者，以便提供者及早干预，并帮助自动化调度和出院后随访等行政流程。
这笔 1.1 亿美元融资包括由 Andreessen Horowitz 领投的 5000 万美元股权融资，Viking Global Investors、AlleyCorp 和 Ulysses Capital 参与投资，以及由 Trinity Capital 领投的 6000 万美元债务融资。借助这笔资金，Pearl 将扩展其 AI 平台，并通过新的医疗系统和支付方合作伙伴关系继续增长，同时扩展到 Medicare Advantage。
图片来源：Abscent84，Getty Images
Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive.
Health tech companies made several major funding announcements in July. Here is a list of some of the biggest funding rounds.
Function rakes in $450 million in funding Austin, Texas-based Function Health is a platform that gives consumers access to more than 160 different lab tests, including for hormones, heart health, immunity and metabolism. An annual subscription to the platform costs $365.
Its $450 million in growth funding is from General Catalyst’s Customer Value Fund. The financing will help Function “bring its platform to millions more people faster,” according to the announcement Chai Discovery raises $400 million in Series C funding San Francisco-based Chai Discovery develops a computer-aided design suite for molecules. It trains models to learn the foundations of biochemical structure and interaction to help scientists design new medicines.
Its Series C raise was led by Index Ventures alongside Kleiner Perkins, Sequoia Capital and Dimension. Participation also included Bain Capital Ventures, Battery Ventures, Baillie Gifford, BDT & MSD, Sapphire Ventures, Avra Capital, Thrive Capital, OpenAI, Oak HC/FT, Menlo Ventures, General Catalyst, Glade Brook, Avenir, Lachy Groom and Yosemite. Chai Discovery is now valued at $3.8 billion.
Candid Health secures $120 million in Series D funding San Francisco-based Candid Health serves medical groups, managed service organizations and digital health companies. Its AI-powered system automates medical billing and health insurance claims to help providers get paid more accurately and quickly. It supports more than 200 healthcare organizations, including Talkiatry, Tia, Luna, Cortica and Nourish. The funding will support continued investment in automation, accelerate development of agentic RCM solutions and grow its team, Candid Health said.
The Series D round was led by Sixth Street Growth, with participation from Oak HC/FT, 8VC and Y Combinator. This comes after a $52.5 million Series C raise in February 2025 led by Oak HC/FT. In total, Candid Health has raised about $219 million.
Pearl Health lands $110 million in funding New York-based Pearl Health supports clinicians and care organizations in engaging in value-based care by offering AI-powered predictive insights, financial risk modeling and more efficient workflows. Its platform helps identify at-risk patients so providers can intervene early, and helps automate administrative processes like scheduling and post-discharge follow-ups.
The $110 million raise includes a $50 million equity investment led by Andreessen Horowitz with participation from Viking Global Investors, AlleyCorp and Ulysses Capital, as well as a $60 million debt facility led by Trinity Capital. With the funding, Pearl will expand its AI platform, as well as continue to grow via new health system and payer partnerships, and expand into Medicare Advantage.
Photo: Abscent84, Getty Images